The goal of this real-world, multi-center, randomized, outpatient study is to assess the effectiveness of the Biofourmis cloud based BiovitalsHFTM Clinical Decision Support Platform to recommend optimal titration of Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) subjects.
Contact phoneSparrow Clinical Research Institute 517.364.5760
Principal investigatorChad Link, D.O.
Trial CategoryHeart & Vascular
Trial SubCategoryHeart Failure